{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T20:40:09Z","timestamp":1750538409278,"version":"3.41.0"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2022,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>A 74-year-old man presenting with biochemical recurrent prostate cancer 9 months after robotic-assisted radical prostatectomy and pelvic lymphadenectomy underwent <jats:sup>18<\/jats:sup>F-fluciclovine PET\/CT for restaging to determine subsequent treatment strategy. Serum prostate-specific antigen was 0.7 ng\/mL at the time of imaging. Images demonstrated foci of abnormal increased <jats:sup>18<\/jats:sup>F-fluciclovine uptake corresponding to prominent round lymph nodes in the left axilla, some of which with fatty hila. Due to recent mRNA COVID-19 vaccination in the ipsilateral arm and the low likelihood of nodal metastases to the axilla from prostate cancer in this patient, the lymph nodes were considered to be benign, reactive to the vaccine.<\/jats:p>","DOI":"10.1097\/rlu.0000000000003844","type":"journal-article","created":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T08:56:41Z","timestamp":1624957001000},"page":"154-155","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["18F-Fluciclovine\u2013Avid Reactive Axillary Lymph Nodes After COVID-19 Vaccination"],"prefix":"10.1097","volume":"47","author":[{"given":"Franklin C.","family":"Wong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia","family":"Martiniova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avantika","family":"Masrani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory C.","family":"Ravizzini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,6,29]]},"reference":[{"key":"bib1-20250621","first-page":"331","article-title":"Synthesis and evaluation of [18F]1-amino-3-fluorocyclobutane-1-carboxylic acid to image brain tumors","volume":"40","year":"1999","journal-title":"J Nucl Med"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"822","DOI":"10.2967\/jnumed.110.086074","article-title":"Putative transport mechanism and intracellular fate of trans-1-amino-3-18F-fluorocyclobutanecarboxylic acid in human prostate cancer","volume":"52","year":"2011","journal-title":"J Nucl Med"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.2967\/jnumed.115.171389","article-title":"Anti-3-18F-FACBC (18F-Fluciclovine) PET\/CT of breast cancer: an exploratory study","volume":"57","year":"2016","journal-title":"J Nucl Med"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"e367","DOI":"10.1097\/RLU.0000000000002507","article-title":"Incidentally detected oropharyngeal squamous cell carcinoma on 18F-fluciclovine PET\/CT","volume":"44","year":"2019","journal-title":"Clin Nucl Med"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1097\/RLU.0000000000001789","article-title":"Recurrent malignant melanoma detected on 18F-fluciclovine PET\/CT imaging for prostate cancer","volume":"42","year":"2017","journal-title":"Clin Nucl Med"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.2967\/jnumed.114.143628","article-title":"Anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid: physiologic uptake patterns, incidental findings, and variants that may simulate disease","volume":"55","year":"2014","journal-title":"J Nucl Med"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/RLU.0000000000003635","article-title":"COVID-19 vaccination manifesting as incidental lymph nodal uptake on 18F-FDG PET\/CT","volume":"46","year":"2021","journal-title":"Clin Nucl Med"},{"journal-title":"Clin Nucl Med","article-title":"The challenge of staging breast cancer with PET\/CT in the era of COVID vaccination","year":"2021","key":"bib8-20250621"},{"key":"bib9-20250621","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/RLU.0000000000003633","article-title":"18F-FDG-avid lymph nodes after COVID-19 vaccination on 18F-FDG PET\/CT","volume":"46","year":"2021","journal-title":"Clin Nucl Med"},{"journal-title":"Clin Nucl Med","article-title":"DOTATATE-avid bilateral axilla and subpectoral lymphadenopathy induced from COVID-19 mRNA vaccination visualized on PET\/CT","year":"2021","key":"bib10-20250621"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003844","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T20:07:18Z","timestamp":1750536438000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003844"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,29]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000003844","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"type":"electronic","value":"1536-0229"},{"type":"print","value":"0363-9762"}],"subject":[],"published":{"date-parts":[[2021,6,29]]}}}